Guidelines for the use of biochemical markers of bone turnover in osteoporosis (2004)

被引：129

作者：

Nishizawa, Y

Nakamura, T

Ohta, H

Kushida, K

Gorai, I

Shiraki, M

Fukunaga, M

Hosoi, T

Miki, T

Chaki, O

Ichimura, S

Nakatsuka, K

Miura, M

机构：

[1] Osaka City Univ, Grad Sch Med, Dept Metab Endocrinol & Mol Med, Abeno Ku, Osaka 5458585, Japan

[2] Univ Occupat & Environm Hlth, Sch Med, Dept Orthoped Surg, Kitakyushu, Fukuoka 807, Japan

[3] Tokyo Womens Med Univ, Dept Obstet & Gynecol, Tokyo, Japan

[4] Hamamatsu Univ Sch Med, Dept Orthoped Surg, Hamamatsu, Shizuoka 43131, Japan

[5] Int Univ Hlth & Welf, Atami Hosp, Dept Obstet & Gynecol, Atami, Japan

[6] Res Inst & Practice Involut Dis, Nagano, Japan

[7] Kawasaki Med Sch, Dept Nucl Med, Kurashiki, Okayama, Japan

[8] Tokyo Metropolitan Geriatr Hosp, Endocrinol Sect, Tokyo 173, Japan

[9] Osaka City Univ, Grad Sch Med, Dept Geriatr Med, Osaka 558, Japan

[10] Yokohama City Univ, Dept Obstet & Gynecol, Yokohama, Kanagawa 232, Japan

[11] Kyorin Univ, Sch Med, Dept Orthoped Surg, Mitaka, Tokyo, Japan

[12] Eli Lilly Japan KK, Lilly Res Labs, Kobe, Hyogo, Japan

[13] Mitsubishi Kagaku BCL, R&D Dept, Tokyo, Japan

来源：

JOURNAL OF BONE AND MINERAL METABOLISM | 2005年 / 23卷 / 02期

关键词：

guideline; markers of bone turnover; osteoporosis;

D O I：

10.1007/s00774-004-0547-6

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：97 / 104

页数：8

共 31 条

[1] Six and twelve month changes in bone turnover are related to reduction in vertebral fracture risk during 3 years of raloxifene treatment in postmenopausal osteoporosis [J].

Bjarnason, NH ;

Sarkar, S ;

Duong, T ;

Mitlak, B ;

Delmas, PD ;

Christiansen, C .

OSTEOPOROSIS INTERNATIONAL, 2001, 12 (11) :922-930

[2] Reconsidering the effects of antiresorptive therapies in reducing osteoporotic fracture [J].

Chesnut, CH ;

Rosen, CJ .

JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 (12) :2163-2172

[3] Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs [J].

Cummings, SR ;

Karpf, DB ;

Harris, F ;

Genant, HK ;

Ensrud, K ;

LaCroix, AZ ;

Black, DM .

AMERICAN JOURNAL OF MEDICINE, 2002, 112 (04) :281-289

[4]

Delmas PD, 2003, J BONE MINER RES, V18, pS374

[5]

Delmas PD, 2000, OSTEOPOROSIS INT, V11, P2, DOI 10.1007/s001980070002

[6]

DELMAS PD, 2004, BONE

[7] Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate [J].

Eastell, R ;

Barton, I ;

Hannon, RA ;

Chines, A ;

Garnero, P ;

Delmas, PD .

JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 (06) :1051-1056

[8]

Eastell R, 2003, CONT ENDOCRINOL, P185

[9] Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: The OFELY study [J].

Garnero, P ;

Sornay-Rendu, E ;

Claustrat, B ;

Delmas, PD .

JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 (08) :1526-1536

[10]

Garnero P, 1996, J BONE MINER RES, V11, P1531

← 1 2 3 4 →